HIGH-DOSE PULSE CHLORAMBUCIL - EFFECTIVE THERAPY FOR RAPID REMISSION INDUCTION IN NODULAR LYMPHOCYTIC POORLY DIFFERENTIATED LYMPHOMA

被引:0
|
作者
CADMAN, E
DRISLANE, F
WALDRON, JA
FARBER, L
PROSNITZ, L
BERTINO, JR
机构
[1] YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510
[2] YALE UNIV,SCH MED,DEPT PATHOL,NEW HAVEN,CT 06510
[3] YALE UNIV,SCH MED,DEPT THERAPEUT RADIOL,NEW HAVEN,CT 06510
关键词
D O I
10.1002/1097-0142(19820915)50:6<1037::AID-CNCR2820500603>3.0.CO;2-N
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1037 / 1041
页数:5
相关论文
共 50 条
  • [41] HIGH-DOSE METHOTREXATE AS PART OF REMISSION MAINTENANCE THERAPY FOR CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP PILOT-STUDY
    FRANKEL, LS
    WANG, YM
    SHUSTER, J
    NITSCHKE, R
    DOERING, EJ
    PULLEN, J
    JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (12) : 804 - 809
  • [42] High-dose cyclophosphamide following autologous BMT is safe and effective as salvage therapy for persistent or sensitive relapsed malignant lymphoma
    De Souza, CA
    Baldissera, RC
    Vigorito, AC
    Aranha, JFP
    Oliveira, GB
    Eid, KAB
    Miranda, ECM
    BONE MARROW TRANSPLANTATION, 2001, 27 : S271 - S271
  • [43] High-dose methotrexate-based chemotherapy for induction remission of newly diagnosed primary CNS lymphoma: A systematic review and meta-analysis
    Shi, Han
    Sun, Xuefei
    Wu, Yuchen
    Cui, Qu
    Sun, Shengjun
    Ji, Nan
    Liu, Yuanbo
    MEDICINE, 2025, 104 (05)
  • [44] Remission of the Renal Involvement in a Patient with Primary Sjo¨gren’s Syndrome (SS) after Pulse High-Dose Corticosteroid Infusion Therapy
    Y. Saeki
    S. Ohshima
    T. Ishida
    Y. Shima
    M. Umeshita-Sasai
    K. Nishioka
    N. Yamaguchi
    M. Suemura
    Clinical Rheumatology, 2001, 20 : 225 - 228
  • [45] Timed sequential therapy with high-dose cytarabine and mitoxantrone as an effective and safe induction regimen for acute myeloid leukemia.
    Larson, Melissa L.
    Burhani, Sakina
    Gallas, Kirstin
    Katz, Deborah Ann
    Hoyt, Maura
    Venugopal, Parameswaran
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial
    Horning, SJ
    Negrin, RS
    Hoppe, RT
    Rosenberg, SA
    Chao, NJ
    Long, GD
    Brown, BW
    Blume, KG
    BLOOD, 2001, 97 (02) : 404 - 409
  • [47] High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission
    Papajik, T.
    Raida, L.
    Faber, E.
    Vondrakova, J.
    Prochazka, V.
    Kubova, Z.
    Skoumalova, I.
    Jarosova, M.
    Kucerova, L.
    Tichy, M.
    Paucek, B.
    Myslivecek, M.
    Neoral, C.
    Oral, I.
    Jarkovsky, J.
    Dusek, L.
    Indrak, K.
    NEOPLASMA, 2008, 55 (03) : 215 - 221
  • [48] Consolidation therapy with high-dose cyclophosphamide (HDC) reduces minimal residual disease in patients with chronic lymphocytic leukemia (CLL) treated with fludarabine as induction therapy.
    Weiss, M
    Glenn, M
    Maslak, P
    Rahman, Z
    Megherian, L
    Noy, A
    Zelenetz, A
    Scheinberg, D
    Golde, D
    BLOOD, 1996, 88 (10) : 1911 - 1911
  • [49] Mantle cell lymphoma (MCL):: Induction therapy with HyperCVAD/High-dose methotrexate and cytarabine (M-C) (±rituximab) improves results of autologous stem cell transplant in first remission.
    Vose, J.
    Loberiza, F.
    Bierman, P.
    Bociek, G.
    Armitage, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 424S - 424S
  • [50] PROLONGED REMISSION OF SMALL CELL LUNG-CARCINOMA (SCLC) WITH INTENSIVE CHEMOTHERAPY INDUCTION AND HIGH-DOSE RADIATION-THERAPY WITHOUT MAINTENANCE
    NATALE, R
    HILARIS, B
    WITTES, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 452 - 452